Get my own profile
Public access
View all18 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Andreas BenderUniversity of Cambridge; Pangea Bio; Universitatea Babeș-Bolyai; UMF ClujVerified email at cam.ac.uk
- Meir GlickDirector, Structural Chemistry, Merck & CoVerified email at merck.com
- Josef ScheiberManaging Director at BioVariance GmbHVerified email at josef-scheiber.de
- Steven WhitebreadRetiredVerified email at one-name.org
- Laszlo UrbanHead of Preclinical Secondary Pharmacology, NIBRVerified email at novartis.com
- Eugen LounkineNovartis Institutes for Biomedical Research Inc.Verified email at novartis.com
- Florian NigschDirector Data Science, Novartis Institutes for BioMedical ResearchVerified email at flo.nigsch.com
- Marc HildSenior Investigator I, Novartis Institutes for BioMedical ResearchVerified email at novartis.com
- Chetan SukuruSenior Director, Research Informatics, Tango TherapeuticsVerified email at tangotx.com
- James NettlesEmory University Verified email at emory.edu
- Yuan WangUCB Biosciences, Bedford, MA, USAVerified email at ucb.com
- Markus SchirleNovartis Biomedical ResearchVerified email at novartis.com
- John A. TallaricoNovartis Biomedical ResearchVerified email at novartis.com
- Mariusz MilikSelvita S.A.Verified email at selvita.com
- Brian ShoichetProfessor of Pharmaceutical Chemistry, University of California, San FranciscoVerified email at cgl.ucsf.edu
- Bin ChenMichigan State UniversityVerified email at hc.msu.edu